Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-05

Clinical Trial Update: The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands [NA]

View source ↗

Summary

A completed clinical trial comparing Narrow-Band UVB therapy to Excilite treatment for vitiligo after minigrafting on the dorsal hands; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Excilite treatment (Excilite)
  • Narrow-Band Ultraviolet B (NBUVB) (NBUVB)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Vitiligo | NA | Status: COMPLETED | Results posted: 2019-11-05